Sorry, you need to enable JavaScript to visit this website.

Pfizer recognizes the public concern in relation to COVID-19, which continues to evolve.

Click here to learn how we are responding.

Skip to main content
Home

Main navigation

  • Homepage
  • About clinical trials

    About
    clinical trials

    Visit About Clinical Trials page

    About Trial submenu

    • How clinical trials work
    • Protecting your safety & privacy
    • Diversity in clinical trials
    • Steps to join a clinical trial
    • For caregivers
    • Pediatric clinical trials
    • FAQs
  • Our research

    Our research

    Visit Our Research page

    Our research submenu

    • Inflammation & Immunology
    • Internal Medicine
    • Oncology
    • Rare Diseases
    • Vaccines
    • Pfizer Clinical Research Unit (PCRU)
  • For participants

    For participants

    For participants

    • For current clinical trial participants
    • For past clinical trial participants
  • Find a trial

    Find a Pfizer clinical trial

    Sex
    Male
    Female
    Pediatric Trials: 0-17 Years
    Adult Trials: 18+ Years
    0 - 17
    18 - 64
    65+
    Indicates the current stage of a clinical study and whether it is or will be open for enrollment or in currently active and enrolling in the near future.
    • 50
    • 100
    • 150
    • 200
    • 250+
    250+
    1000
    Show Filters
    Male Female 0 - 17 Years 18 - 64 Years 65+ Years 50 100 150 200 250+
    loader

    Searching for Matching Trials ...

Contact us

For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.

22 trials found

Find a Pfizer clinical trial

Sex
Male
Female
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
0 - 17
18 - 64
65+
Indicates the current stage of a clinical study and whether it is or will be open for enrollment or in currently active and enrolling in the near future.
  • 50
  • 100
  • 150
  • 200
  • 250+
250+
1000
Show Filters
MaleFemale0 - 17 Years18 - 64 Years65+ Years50100150200250+
loader

Searching for Matching Trials ...

22 trials found forLeukemia
  • Save search
  • Saved trials
PrintEmail
All (22)Recruiting (22)Not yet recruiting (0)
Acute Myelogenous Leukemia (AML) Due to Therapy, Acute Myeloid Leukemia With Myelodysplasia-Related Changes
CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
NCT04231851
Recruiting
Male or Female
18+
years
6570
Multiple Sites
6570
2study location(s)
Locations for this trial:
Moores Cancer Center, Unversity of California, San Diego
La Jolla, California, 92093
United States
Chao Family Comprehensive Cancer Center, University of California, Irvine
Orange, California, 92868
United States
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
Study of Palbociclib in MLL-rearranged Acute Leukemias
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
NCT02310243
Recruiting
Male or Female
18+
years
6570
Multiple Sites
6570
24study location(s)
Locations for this trial:
Klinikum Augsburg
Augsburg, 86156
Germany
Helios Klinikum Bad Saarow
Bad Saarow, 15526
Germany
Charité Campus Benjamin Franklin
Berlin, 12200
Germany
Vivantes Klinikum Neukölln
Berlin, 12351
Germany
Charité Campus Virchow-Klinikum
Berlin, 13353
Germany
Universitätsklinikum Bonn
Bonn, 53105
Germany
Städtisches Klinikum Braunschweig gGmbH
Braunschweig, 38114
Germany
Universitätsklinikum Düsseldorf
Düsseldorf, 40225
Germany
Kliniken Essen Süd, Ev. Krankenhaus Essen-Werden gGmbH
Essen, 45239
Germany
Malteser Krankenhaus St. Franziskus-Hospital
Flensburg, 24939
Germany
Universitätsklinikum Freiburg
Freiburg, 791016
Germany
MVZ Osthessen
Fulda, 36043
Germany
Universitätsklinikum Giessen
Giessen, 35392
Germany
Universitätsklinikum Hamburg-Eppendorf
Hamburg, 20246
Germany
Medizinische Hochschule Hannover
Hannover, 30625
Germany
Universitätsklinikum Heidelberg
Heidelberg, 69120
Germany
Städtisches Klinikum Karlsruhe gGmbH
Karlsruhe, 76133
Germany
Universitätsklinikum Schleswig-Holstein Campus Kiel
Kiel, 24116
Germany
Caritas-Krankenhaus Lebach
Lebach, 66822
Germany
Uni-Klinikum der Otto-von-Guericke-Universität
Magdeburg, 39120
Germany
Universitätsmedizin der Johannes Gutenberg-Universität
Mainz, 55131
Germany
Pius Hospital Oldenburg
Oldenburg, 26121
Germany
Medizinische Universitätsklinik Tübingen
Tübingen, 72076
Germany
University Hospital of Ulm
Ulm, 89081
Germany
Acute Myeloid Leukemia
Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
NCT03839446
Recruiting
Male or Female
18 - 75
years
6570
Pittsburgh, Pennsylvania
6570
1study location(s)
Locations for this trial:
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232
United States
Chronic Myelogenous Leukemia
Safety And Efficacy Of Bosutinib
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
NCT02501330
Recruiting
Male or Female
Shibuya-ku,
1study location(s)
Locations for this trial:
Shibuya-ku, 151-8589
Japan
Acute Lymphoblastic Leukemia
Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
NCT03913559
Recruiting
Male or Female
Up to 21
years
Memphis, Tennessee
1study location(s)
Locations for this trial:
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105
United States
Precursor Cell Lymphoblastic Leukemia-Lymphoma
InO - A Retrospective Study of UK Patients With Leukaemia
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
NCT04456959
Recruiting
Male or Female
18+
years
6570
Multiple Sites
6570
3study location(s)
Locations for this trial:
University Hospitals Bristol NHS Foundation Trust
Bristol, Somerset, BS1 3NU
United Kingdom
Taunton and Somerset NHS Foundation Trust of Musgrove Park Hospital
Taunton, Somerset, TA1 5DA
United Kingdom
The Royal Marsden NHS Foundation Trust
Sutton, Surrey, SM2 5PT
United Kingdom
Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Talazoparib and Gemtuzumab Ozogamicin for the Treatment of CD33 Positive Relapsed or Refractory Acute Myeloid Leukemia
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
NCT04207190
Recruiting
Male or Female
18+
years
6570
Buffalo, New York
6570
1study location(s)
Locations for this trial:
Roswell Park Cancer Institute
Buffalo, New York, 14263
United States
Acute Myeloid Leukemia
Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
NCT03374332
Recruiting
Male or Female
18+
years
6570
Providence, Rhode Island
6570
1study location(s)
Locations for this trial:
Rhode Island Hospital
Providence, Rhode Island, 02903
United States
B-cell Acute Lymphoblastic Leukemia
Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Younger Adults With Relapsed/Refractory B-cell ALL
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
NCT03962465
Recruiting
Male or Female
18 - 55
years
6570
Charlottesville, Virginia
6570
1study location(s)
Locations for this trial:
University of Virginia
Charlottesville, Virginia, 22908
United States
Acute Myeloid Leukemia
CPX-351+GO in Subjects 55 Years Old, or Older, With AML
NCT# stands for National Clinical Trial number. This is a unique identification code given to each clinical trial registered on ClinicalTrials.gov. The format is "NCT" followed by an 8-digit number (for example, NCT00000419). Also called the ClinicalTrials.gov identifier.
NCT03878927
Recruiting
Male or Female
55+
years
20075
New York, New York
20075
1study location(s)
Locations for this trial:
Weill Cornell Medical College
New York, New York, 10021
United States

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next pageNext ›
  • Last pageLast »

Saved trials

You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

Information on this website is directed toward U.S. residents only.

© 2020 Pfizer Inc. All rights reserved.

Social links menu

  • Facebook
  • Youtube
  • Instagram

Footer

  • About Pfizer
  • For investigators
  • Contact us

Footer menu

  • Site map
  • Terms of use
  • Privacy policy